Maoyong Fu

656 total citations
28 papers, 349 citations indexed

About

Maoyong Fu is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Maoyong Fu has authored 28 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 8 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Maoyong Fu's work include Esophageal Cancer Research and Treatment (6 papers), Gastric Cancer Management and Outcomes (6 papers) and RNA modifications and cancer (4 papers). Maoyong Fu is often cited by papers focused on Esophageal Cancer Research and Treatment (6 papers), Gastric Cancer Management and Outcomes (6 papers) and RNA modifications and cancer (4 papers). Maoyong Fu collaborates with scholars based in China, United States and Taiwan. Maoyong Fu's co-authors include Madhuri Wadehra, Jonathan Braun, Lynn K. Gordon, Samuel S. Epstein, K. S. Lavappa, Lee Goodglick, Puneet Dhawan, Erin L. Maresh, Robert A. Soslow and Ann M. Chan and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Oncogene.

In The Last Decade

Maoyong Fu

23 papers receiving 342 citations

Peers

Maoyong Fu
Alberto Berjón Spain
Caitlin Foley United States
Reino Pitkänen Finland
Kate M. Im United States
Anne Tann United States
PengXin Zhang China
Chikako Fukukawa Japan
Katherine S. Meise United States
Christopher Newton United States
Dongying Chen United States
Alberto Berjón Spain
Maoyong Fu
Citations per year, relative to Maoyong Fu Maoyong Fu (= 1×) peers Alberto Berjón

Countries citing papers authored by Maoyong Fu

Since Specialization
Citations

This map shows the geographic impact of Maoyong Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maoyong Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maoyong Fu more than expected).

Fields of papers citing papers by Maoyong Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maoyong Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maoyong Fu. The network helps show where Maoyong Fu may publish in the future.

Co-authorship network of co-authors of Maoyong Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Maoyong Fu. A scholar is included among the top collaborators of Maoyong Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maoyong Fu. Maoyong Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhang, Chengcheng, Tao Luo, Yue Zhang, et al.. (2025). Survival Benefits of Neoadjuvant Immunochemotherapy Versus Chemotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Propensity Matched Score. Journal of Gastrointestinal Cancer. 56(1). 167–167.
3.
Liu, Junhong, Yue Zhang, Tao Luo, et al.. (2025). Impact of skeletal muscle loss and sarcopenia on outcomes of neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma. Frontiers in Nutrition. 12. 1650337–1650337.
4.
Liang, Shufang, Maoyong Fu, Yehui Shi, et al.. (2025). Arsenic trioxide enhances the inhibitory effect of lenvatinib on hepatocellular carcinoma through HMOX1-mediated ferroptosis. International Immunopharmacology. 167. 115656–115656.
5.
Zhang, Chengcheng, Tao Luo, Yue Zhang, et al.. (2024). Clinical outcomes of conversion surgery after induction immunochemotherapy for borderline resectable T4 esophageal squamous cell carcinoma. World Journal of Surgical Oncology. 22(1). 288–288. 1 indexed citations
6.
Dong, Ning, et al.. (2024). Safety and efficacy of thrombolytic therapy in the treatment of early pulmonary embolism after thoracic surgery. Journal of Thoracic Disease. 16(10). 6417–6426.
7.
Li, Yin, Jianjun Qin, Liyan Xue, et al.. (2024). Chemotherapy plus camrelizumab versus chemotherapy alone as neoadjuvant treatment for resectable esophageal squamous cell carcinoma (ESCORT-NEO): A multi-center, randomized phase III trial.. Journal of Clinical Oncology. 42(3_suppl). LBA244–LBA244. 12 indexed citations
8.
Tian, Dong, et al.. (2018). Investigation of Dietary Factors and Esophageal Cancer Knowledge: Comparison of Rural Residents in High- and Low-incidence Areas. Scientific Reports. 8(1). 4914–4914. 12 indexed citations
9.
Tian, Dong, et al.. (2016). Pulmonary chondroma: A clinicopathological study of 29 cases and a review of the literature. Molecular and Clinical Oncology. 5(3). 211–215. 4 indexed citations
10.
Yel, Leman, Charlotte Cunningham‐Rundles, Jordan S. Orange, et al.. (2015). A Novel Targeted Screening Tool for Hypogammaglobulinemia: Measurement of Serum Immunoglobulin (IgG, IgM, IgA) Levels from Dried Blood Spots (Ig-DBS Assay). Journal of Clinical Immunology. 35(6). 573–582. 13 indexed citations
11.
Fu, Maoyong, Erin L. Maresh, Gustavo Helguera, et al.. (2014). Rationale and Preclinical Efficacy of a Novel Anti-EMP2 Antibody for the Treatment of Invasive Breast Cancer. Molecular Cancer Therapeutics. 13(4). 902–915. 41 indexed citations
12.
Yu, Qin, Maoyong Fu, Masamichi Takahashi, et al.. (2014). Epithelial Membrane Protein-2 (EMP2) Activates Src Protein and Is a Novel Therapeutic Target for Glioblastoma. Journal of Biological Chemistry. 289(20). 13974–13985. 36 indexed citations
13.
Wu, Bihua, et al.. (2013). Overexpression of ECRG4 enhances chemosensitivity to 5-fluorouracil in the human gastric cancer SGC-7901 cell line. Tumor Biology. 34(4). 2269–2273. 20 indexed citations
14.
Gordon, Lynn K., Maoyong Fu, Jonathan Braun, et al.. (2013). EMP2 regulates angiogenesis in endometrial cancer cells through induction of VEGF. Oncogene. 32(46). 5369–5376. 47 indexed citations
15.
Fu, Maoyong, Sarah Brewer, Tove Olafsen, et al.. (2012). Positron Emission Tomography Imaging of Endometrial Cancer Using Engineered Anti-EMP2 Antibody Fragments. Molecular Imaging and Biology. 15(1). 68–78. 19 indexed citations
16.
17.
Tian, Li & Maoyong Fu. (2011). The relationship between high density lipoprotein subclass profile and apolipoprotein concentrations. Journal of Endocrinological Investigation. 34(6). 461–472. 6 indexed citations
18.
Fu, Maoyong, Erin L. Maresh, Robert A. Soslow, et al.. (2010). Epithelial Membrane Protein-2 Is a Novel Therapeutic Target in Ovarian Cancer. Clinical Cancer Research. 16(15). 3954–3963. 32 indexed citations
19.
Zhan, Lingling, et al.. (1998). [Study on the adhesion of an endemic strain of Streptococcus mutans serotype C to acquired pellicle. II. Isolation and extraction of adhesins of an endemic strain of Streptococcus mutans serotype C].. PubMed. 16(1). 76–9. 1 indexed citations
20.
Fu, Maoyong, et al.. (1996). [Comparison of diet, physical activity and serum lipids between Chinese and Japanese: Chengdu-Fukuoka Study].. PubMed. 27(1). 26–30. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alberto Berjón Breakdown of academic impact, for papers by Caitlin Foley Breakdown of academic impact, for papers by Reino Pitkänen Breakdown of academic impact, for papers by Kate M. Im Breakdown of academic impact, for papers by Anne Tann Breakdown of academic impact, for papers by PengXin Zhang Breakdown of academic impact, for papers by Chikako Fukukawa Breakdown of academic impact, for papers by Katherine S. Meise Breakdown of academic impact, for papers by Christopher Newton Breakdown of academic impact, for papers by Dongying Chen
Rankless by CCL
2026